Prevention of duodenal ulcer recurrence with 15 mg lansoprazole: A double-blind placebo-controlled study

Digestive Diseases and Sciences

Volumn 42, Issue 12, 1997, Pages 2529-2536

  Lanza, Frank ^a   Goff, John ^a   Silvers, David ^a   Winters, Joan ^a   Jhala, Nirag ^a   Jennings, Dennis ^a   Greski Rose, Pamela ^a  

^a NONE

Author keywords

Duodenal ulcer; Lansoprazole; Proton pump inhibitor; Serum gastrin

Indexed keywords

ATTAPULGITE; GASTRIN; LANSOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; SEROTONIN; SOMATOSTATIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DUODENUM ULCER; ENDOSCOPY; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT PEPTIC ULCER; STOMACH ACID; STOMACH BIOPSY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTI-ULCER AGENTS; BIOPSY; DOUBLE-BLIND METHOD; DUODENAL ULCER; FEMALE; GASTRINS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; RECURRENCE;

EID: 0031431559     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018868713520     Document Type: Article

References (37)

1. Soll A: Medical treatment of peptic ulcer disease: Practice guidelines. JAMA 275(8):622-629, 1996
2. Walsh JH, Peterson WL: The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 333:984-991, 1995
3. Barradell LB, Faulds D, McTavish D: Lansoprazole: A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs 44(2):225-250, 1992
4. Hotz J, Kleiner R, Grymbowski T, Hennig U, Schwartz JA: Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration. Aliment Pharmacol Ther 6:87-95, 1992
5. Lanza F, Goff J, Scowcroft C, Jennings D, Greski-Rose P, Lansoprazole Study Group: Double-blind comparison of lansoprazole, ranitidine and placebo in the treatment of acute duodenal ulcer. Am J Gastroenterol 89:1191-1200, 1994
6. Londong W, Barth H, Dammann HG, Hengels KJ, Kleinert R, Muller P, Ronde H, Simon B: Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Aliment Pharmacol Ther 5:245-254, 1991
7. Wormsley KG, Bardhan KD, Morgan AG, Hislop W, Long R, Hellers G, Ahlberg J, Lindholmer C, Langworthy H, Moules I: Lansoprazole (LAN) is more effective than ranitidine (RAN) in the healing of gastric ulcer (GU). Abstract T190. Gut 33(suppl 1):548, 1992
8. Petite JP, Grimaud JC, Rautureau J, Lemaire M: Lansoprazole versus omeprazole dans la traitement de l'ulcere duodenal evolutif. Gastroenterol Clin Biol 15:A111, 1991 (abstract)
9. Hui WM, Lam SK, Lok ASF, Ng MMT, Lai CL: Maintenance therapy for duodenal ulcer: A randomized controlled comparison of seven forms of treatment. Amer J Med 92:265-274, 1992
10. Sonnenberg A: Comparison of different strategies for treatment of duodenal ulcer. Br Med J 290:1185-1187, 1985
11. Graham DY, Colon-Pagan J, Morse RS, Johnson TL, Walsh JH, McCullough AJ, Mark JW, Sklar M, Stone RC, Cagliola AJ, Walton-Bowen KL, Humphries TJ, Omeprazole Duodenal Ulcer Study Group: Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: A double-blind, multicenter, 6-month study. Gastroenterology 102:1289-1294, 1992
12. Brinn N: Rapid metallic histologic staining using the microwave oven. J Histotechnol 6:125-129, 1983
13. Solcia E, Bordi C, Creutzfeldt W, Dayal C, Dayan AD, Falkmer S, Grimelius L, Havu N: Histopathological classification of nonantral gastric endocrine growths in man. Digestion 41:185-200, 1988
14. Owen DW: The diagnosis and significance of gastritis. In Pathology Annual I, Vol 14. SC Sommers, SC Rosen (eds). New York, Appleton-Century-Crofts, 1979, pp 247-291
15. Hsu SM, Raine L, Fanger H: A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. J Clin Pathol 75:734-738, 1981
16. Vail K: The Warthin-Starry impregnation technique with the microwave oven. Histo-Logic 17(1):235, 1987
17. Solcia E, Fiocca R, Havu N, Dalvag A, Carlsson R: Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion 51(suppl 1):82-92, 1992
18. Fleiss JL: Statistical Methods for Rates and Proportions, 2nd ed. New York, John Wiley & Sons, 1981
19. Cochran WG., Cox GM: Experimental Designs, 2nd ed. New York, John Wiley & Sons, 1957
20. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst 22:719-748, 1959
21. Koch G, McCauless I, Ward J: Interpretation of statistical methodology associated with maintenance trials. Am J Med 77(suppl 5B):43-50, 1984
22. Lehmann EL: Nonparametrics: Statistical Methods Based on Ranks. San Francisco, Holden-Day, 1975
23. Graham DY, Lew GM, Klein PD, Evens DG, Evans DJ, Saeed ZA, Malaty HM: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: A randomized, controlled study. Ann Intern Med 116:705-708, 1992
24. Hentschel E, Brandstätter G, Dragosics B, et al: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328:308-312, 1993
25. NIH Consensus Development Panel: Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69, 1994
26. Lambert JR: Pharmacology of the gastric mucosa: A rational approach to Helicobacter polytherapy. Gastroenterology 111(2):521-523, 1996
27. Penston JG: Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment Pharmacol Ther 8:369-389, 1994
28. Cutler AF, Schubert TT: Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 88:1359-1361, 1993
29. Borody TJ, Cole P, Noonan S, Morgan A, Lenne J, Hyland L, Brandl S, Borody EG, George LL: Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 151:432-435, 1989
30. Patchett S, Beattie S, Leen E, Keane C, O'Morain C: Helicobacter pylori and duodenal ulcer recurrence. Am J Gastroenterol 87(1):24-27, 1992
31. Hopkins RJ, Girardi LS, Turney BA: Helicobacter pylori eradication as a surrogate for reduced peptic ulcer recurrence: A literature-based meta-analysis. VIIIth International Workshop on Gastro-duodenal Pathology and Helicobacter pylori, Edinburgh, Scotland, July 7-9, 1995. Abstract 181. Gut 37(suppl 1):A-16, 1995
32. Daw MA, Deegan P, Leen E, O'Morain C: Short report: The effect of omeprazole on Helicobacter pylori and associated gastritis. Aliment Pharmacol Ther 5(4):435-439, 1991
33. Koop H, Stumpf M, Eissele R, Lamberts R, Stockmann F, Creutzfeldt W, Arnold R: Antral Helicobacter pylori-like organisms in different states of gastric acid secretion. Digestion 48(4):230-236, 1991
34. Sharma BK, Santana IA, Wood EC, Walt RP, Pereira M, Noone P, Smith PLR, Walters CL, Pounder RE: Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J 289:717-719, 1984
35. Iwahi T, Satoh H, Nakao M, Iwasake T, Yamazaki T, Kubo K, Tamura T, Imada A: Lansoprazole, a novel benzimidazole proton pump inhibitor and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 35:490-496, 1991
36. Megraud F, Boyanova L, Lamouliatte H: Activity of lansoprazole against Helicobacter pylori. Lancet 337:1486, 1991 (letter)
37. Yeomans ND: Maintenance therapy for duodenal ulcer with proton pump blockers. J Gatroenterol Hepatol 10:110-111, 1995